C.H. Robinson 10-Q: Q3 EPS Up 24.6%, Buybacks Paused for $5.8B RXO Deal
CHRW is trading near its 52-week low of $122.21 (0.5% above the low).
Summary
C.H. Robinson's Q3 10-Q confirms 24.6% EPS growth to $1.67 but shows operating cash flow collapsing to $228.6 million on a working capital build, debt nearly doubling to $1.869 billion, and buybacks paused to fund the $5.8 billion RXO deal.
Key Events · Earnings and Guidance · CHRW
-
Q3 EPS Up 24.6% to $1.67
Net income rose 21.8% to $198.5 million on total revenues of $5.358 billion, up 29.5%, with adjusted gross profits of $808.4 million (+14.5%) and adjusted operating margin of 33.6%, up 230 basis points.
-
Operating Cash Flow Falls to $228.6M
Nine-month operating cash flow dropped from $609.1 million to $228.6 million as receivables absorbed $1.22 billion and contract assets $134.9 million, reflecting higher freight pricing and costs.
-
Debt Nearly Doubles, Buybacks Paused
Total debt rose to $1.869 billion from $1.089 billion at December 31, 2025; the company repurchased $639.9 million of stock in the first nine months but has now paused repurchases to pay down debt ahead of the RXO acquisition.
-
$604M Verdict Carries Joint-and-Several Risk
The July 23, 2026 Lipe verdict assigned 23% of $604 million in damages to C.H. Robinson but the jury found vicarious liability, exposing the company to the full amount plus $107 million of pre-judgment interest against $155 million of insurance coverage per occurrence.
Analysis · CHRW · Energy & Transportation
The quarter itself was already public in the October 28 8-K, so the new information is in the detail: operating cash flow fell to $228.6 million for the nine months from $609.1 million a year earlier as receivables and contract assets absorbed $1.22 billion of working capital, and total debt climbed to $1.869 billion from $1.089 billion at year-end. Management also disclosed it has paused share repurchases to pay down debt ahead of the RXO acquisition, removing a support that had absorbed $639.9 million of stock in the first nine months. The $604 million Lipe verdict plus $107 million of pre-judgment interest, with joint-and-several exposure against only $155 million of per-occurrence insurance, remains the largest single swing factor and now carries its own risk factor. The stock sits near its 52-week low, so the market is already pricing the freight cycle and deal risk; the cash conversion and leverage trajectory are what matter from here.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHRW was trading at $122.83 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $14.2B. The 52-week trading range was $122.21 to $210.33. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.